A detailed history of Cacti Asset Management LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Cacti Asset Management LLC holds 1,000 shares of LLY stock, worth $767,760. This represents 0.08% of its overall portfolio holdings.

Number of Shares
1,000
Previous 1,000 -0.0%
Holding current value
$767,760
Previous $905,000 2.21%
% of portfolio
0.08%
Previous 0.09%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 01, 2022

SELL
$234.69 - $291.66 $5.55 Million - $6.89 Million
-23,630 Reduced 95.94%
1,000 $290,000
Q4 2021

Jan 03, 2022

BUY
$224.85 - $279.04 $5.31 Million - $6.59 Million
23,630 Added 2363.0%
24,630 $6.8 Million
Q1 2018

Apr 02, 2018

BUY
$74.21 - $87.6 $74,210 - $87,600
1,000 New
1,000 $77,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $730B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Cacti Asset Management LLC Portfolio

Follow Cacti Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cacti Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cacti Asset Management LLC with notifications on news.